GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.
GT Metabolic Solutions has raised $17.1M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
GT Metabolic Solutions's investors include HealthTech Capital, Ironwood Ventures, Ceros Capital Markets.
GT Metabolic Solutions is headquartered in Saint Michael, United States.
GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.
GT Metabolic Solutions is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GT Metabolic Solutions — Funding & Investors." VCBacked, March 12, 2024, https://www.vcbacked.co/company/gt-metabolic-solutions. Accessed August 14, 2026.
VCBacked. (2024). GT Metabolic Solutions — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/gt-metabolic-solutions
{{cite web |title=GT Metabolic Solutions — Funding & Investors |url=https://www.vcbacked.co/company/gt-metabolic-solutions |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated